E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/3/2010 in the Prospect News PIPE Daily.

New Issue: Arena Pharmaceuticals plans $35.53 million private placement of stock

By Devika Patel

Knoxville, Tenn., June 3 - Arena Pharmaceuticals, Inc. said it negotiated a $35.53 million private placement of stock.

The company will sell 11 million common shares at $3.23 per share to Deerfield Management.

Arena is a San Diego-based biopharmaceutical company.

Issuer:Arena Pharmaceuticals, Inc.
Issue:Common stock
Amount:$35.53 million
Shares:11 million
Price:$3.23
Warrants:No
Investor:Deerfield Management
Pricing date:June 3
Stock symbol:Nasdaq: ARNA
Stock price:$3.23 at close June 2
Market capitalization:$326 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.